Musculoskeletal Tumor Society

SCFJFK regulates osteoblast differentiation through targeting RUNX2

RUNX2 (Runt-related transcription factor 2) is a master regulator of osteogenesis, and its genetic mutations are associated with ~65% cases of cleidocranial dysplasia (CCD), an autosomal dominant abnormal bone development disorder in humans with defective intramembranous bone for...